1,330 results on '"Soriano, Alex"'
Search Results
2. Report of three azole-resistant Aspergillus fumigatus cases with TR34/L98H mutation in hematological patients in Barcelona, Spain
3. K-Means Clustering Identifies Diverse Clinical Phenotypes in COVID-19 Patients: Implications for Mortality Risks and Remdesivir Impact
4. Surgical Treatment of Persistent Pseudomonas aeruginosa Bacteraemia After n-Butyl-2-cyanoacrylate for Gastric Bleeding Varices
5. Multiplex real-time PCR FilmArray performance in the diagnosis of meningoencephalitis: lights and shadows
6. Description of reinfection of joint prosthesis after 2-stage replacement (infection of the 2nd stage prosthesis): A multicenter study
7. Caracterización de la reinfección de prótesis articular tras recambio en 2 tiempos (infección de la prótesis del 2.o tiempo). Un estudio multicéntrico
8. Safety and effectiveness of isavuconazole in real-life non-neutropenic patients
9. Increasing of New CA-MRSA Infections Detected in people living with HIV Who Engage in Chemsex in Barcelona: An Ambispective Study
10. Global trends in carbapenem- and difficult-to-treat-resistance among World Health Organization priority bacterial pathogens: ATLAS surveillance program 2018–2022
11. Clinical evaluation of antifungal de-escalation in Candida infections: A systematic review and meta-analysis
12. Assessing the influence of the COVID-19 pandemic on the incidence, clinical presentation, and clindamycin resistance rates of Streptococcus pyogenes infections
13. Efficacy and safety of an early oral switch in low-risk Staphylococcus aureus bloodstream infection (SABATO): an international, open-label, parallel-group, randomised, controlled, non-inferiority trial
14. Safety and immunogenicity of a recombinant protein RBD fusion heterodimer vaccine against SARS-CoV-2
15. Staphylococcus aureus surgical site infection rates in 5 European countries
16. Antimicrobials in polymethylmethacrylate: from prevention to prosthetic joint infection treatment: basic principles and risk of resistance
17. Time from symptoms onset to remdesivir is associated with the risk of ICU admission: a multicentric analyses
18. Real-Life Data on the Effectiveness and Safety of Cefiderocol in Severely Infected Patients: A Case Series
19. Remdesivir-related cost-effectiveness and cost and resource use evidence in COVID-19: a systematic review
20. Efficacy and safety of rezafungin and caspofungin in candidaemia and invasive candidiasis: pooled data from two prospective randomised controlled trials
21. Impact of Positive Cultures During the Second Stage of a Two-Stage Exchange: Systematic Review and Meta-Analysis
22. Performance of an Autonomous Sanitary Sterilisation Ultraviolet Machine (ASSUM) on terminal disinfection of surgical theaters and rooms of an intensive-intermediate care unit
23. Prevalence and Impact of Unexpected Positive Intraoperative Cultures in Total Hip or Knee Revision Surgery
24. Rezafungin versus Caspofungin in a Phase 2, Randomized, Double-Blind Study for the Treatment of Candidemia and Invasive Candidiasis- The STRIVE Trial
25. The Use and Effectiveness of Ceftazidime–Avibactam in Real-World Clinical Practice: EZTEAM Study
26. Expert Opinion on Dose Regimen and Therapeutic Drug Monitoring for Long-Term Use of Dalbavancin: Expert Review Panel
27. Is an isolated positive sonication fluid culture in revision arthroplasties clinically relevant?
28. Prevention and treatment of C. difficile in cancer patients
29. Breakthrough invasive fungal infection among patients with haematologic malignancies: A national, prospective, and multicentre study
30. Role of bacterial colonisation of vancomycin–gentamicin spacers in two-stage arthroplasty revision surgery: the usefulness of spacer sonication
31. Impact of SARS-CoV-2 viral load and duration of symptoms before hospital admission on the mortality of hospitalized COVID-19 patients
32. Impact of adherence to individual quality-of-care indicators on the prognosis of bloodstream infection due to Staphylococcus aureus: a prospective observational multicentre cohort
33. Rezafungin versus caspofungin for treatment of candidaemia and invasive candidiasis (ReSTORE): a multicentre, double-blind, double-dummy, randomised phase 3 trial
34. The Orthopaedic Device Infection Network: Building an Evidence Base for the Treatment of Periprosthetic Joint Infection Through International Collaboration
35. The Management of Patients at High Risk of Serious COVID-19 Disease: Optimising the Patient Pathway in the Middle East, Africa, and Eastern Europe
36. SAFETY AND IMMUNOGENICITY OF A PHH-1V BOOSTER DOSE AFTER DIFFERENT PRIME VACCINATION SCHEMES AGAINST COVID-19: PHASE III CLINICAL TRIAL FINAL RESULTS UP TO ONE YEAR
37. Emergence of carbapenem-resistant Pseudomonas aeruginosa ST179 producing both IMP-16 and KPC-2: a case study of introduction from Peru to Spain
38. Role of routine suppressive antibiotic therapy after DAIR for acute periprosthetic joint infections
39. An Assessment of a New Rapid Multiplex PCR Assay for the Diagnosis of Meningoencephalitis
40. Clinical Presentation and Outcome of COVID-19 in a Latin American Versus Spanish Population: Matched Case-Control Study
41. Stool donor recruitment – A one-year experience
42. First-generation oral antivirals against SARS-CoV-2
43. Changes in the gut microbiota and risk of colonization by multidrug-resistant bacteria, infection, and death in critical care patients
44. Do Cultures Obtained During Primary THA Predict the Likelihood of Revision?
45. Bacterial co-infection at hospital admission in patients with COVID-19
46. Lack of Prognostic Value of SARS-CoV2 RT-PCR Cycle Threshold in the Community
47. Impact on in-hospital mortality of ceftaroline versus standard of care in community-acquired pneumonia: a propensity-matched analysis
48. C-reactive protein cut-off for early tocilizumab and dexamethasone prescription in hospitalized patients with COVID-19
49. Recommendations for stool donor selection for fecal microbiota transplant. Consensus document endorsed by the Catalan Society of Digestology, Catalan Society of Infectious diseases and Clinical Microbiology and the GEMBIOTA group from Spanish Society of Infectious Diseases and Clinical Microbiology
50. Recomendaciones para la selección del donante para la transferencia de microbiota fecal. Documento de posicionamiento avalado por la Societat Catalana de Digestologia, la Societat Catalana de Malalties Infeccioses i Microbiologia Clínica y el grupo GEMBIOTA de la Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.